Which phase of a clinical trial lasts several months and studies drug interactions with the body?

Question

Which phase of a clinical trial lasts several months and studies drug interactions with the body?

BlackTom AI · Accepted Answer

Question restatement: Which phase of a clinical trial lasts several months and studies drug interactions with the body?

Option a) Phase 3: Safety and Efficacy
- Phase 3 trials are large-scale studies primarily focused on confirming efficacy, monitoring adverse reactions, and comparing to standard or existing treatments in diverse populations. They typically occur after Phase 2 and involve many participants, but the primary emphasis is not on studying basic drug interactions with the body over several months.

Option b) Phase 2: Safety and Efficacy
- Phase 2 trials explore effectiveness and side effects in a larger group than Phase 1, and can involve some pharmacokinetics, but this phase is more about preliminary efficacy and dose-ranging rather than the comprehensive study of drug interactions with the body over an extended period.

Option c) Phase 4: Post Marketing Safety and Efficacy
- Phase 4 occurs after a drug is approved and marketed. It monitors long-term safety, rare adverse events, and real-world effectiveness in the general population. It is not the phase that specifically studies initial drug interactions during development.

Option d) Phase 1: Safety and Dosing
- Phase 1 trials are designed to assess safety, tolerability, pharmacokinetics, and how the body handles the drug. They often involve healthy volunteers and, crucially, study drug interactions with the body. This phase typically lasts several months and emphasizes dosing, metabolism, excretion, and potential interactions.

Why the other options are incorrect: The descriptions for Phase 3, Phase 2, and Phase 4 do not center on the initial, in-depth assessment of drug interactions with the body over a several-month period. Phase 3 focuses on efficacy and broader safety in large populations, Phase 2 emphasizes preliminary efficacy and dose finding, and Phase 4 is post-marketing surveillance.

In summary, the phase that lasts several months and studies how the drug interacts with the body is Phase 1: Safety and Dosing.

Which phase of a clinical trial lasts several months and studies drug interactions with the body?

View Explanation

Log in for full answers

Similar Questions

Which of the following are reasons Borgerson gives for thinking that the effectiveness of alternative medicine will not necessarily be demonstrated in large-scale, randomized controlled trials? (Check BOTH that apply)

Which of the following steps comes immediately before Phase I clinical testing?

In Phase III of the Clinical Trial Process, Doctors compare the treatment with the standard of care for that disease. They do so by gathering data from how many patients?

Which of the following occurs during Phase III of the Clinical Trial Process:

At what phase of clinical trials is a drug primarily tested for efficacy in patients who have the disease?

True or False: A single-arm trial includes multiple groups that are randomly assigned to different treatments.

Which of the following best describes Phase 3 of FDA clinical trials?

Which phase of the clinical trial process involves a sample of 100-200 patients to confirm the benefits and safety of a treatment?

More Practical Tools for Students Powered by AI Study Helper

Homework AI Solver

Stylized AI Paper Writer

Plagiarism Checker Assistant

Citation AI Academic Writing Tool

In-Class Translation Assistant

AI Note Generator

AI Quiz Answers

Past Exam Questions from University Test Bank

Smart Practice Assistant

Adaptive Practice

Making Your Study Simpler